Geode in partnership with Baylor Scott & White Health
2401 Calender Road, Suite 105, Mansfield
4.8(283 Google reviews)
United States
3 listed treatment centers serving Mansfield and the surrounding area.
2401 Calender Road, Suite 105, Mansfield
4.8(283 Google reviews)
Every dose is given in a certified healthcare setting, followed by at least two hours of monitoring. Arrange transportation home after each visit. Distances below are straight-line miles from Mansfield.
9 miles away · Arlington
3330 Matlock Road, Suite 202, Arlington
4.5(24 Google reviews)
9.2 miles away · Arlington
11.2 miles away · Cedar Hill
11.7 miles away · Cedar Hill
610 Uptown Boulevard, 2nd Floor, Cedar Hill
4.7(43 Google reviews)
11.7 miles away · Cedar Hill
12.5 miles away · Grand Prairie
For people in Mansfield considering SPRAVATO®, the cost depends on insurance benefits, the treatment setting, and the services billed. Both the medication and the observed treatment and monitoring visit may generate charges. Ask for an estimate that separates these components rather than assuming one quoted charge includes everything.
Prior authorization is common. Your insurer may request records of earlier antidepressant trials, including which medications you tried and how you responded. Ask the treatment center which records it needs, who submits the authorization request, and how you will learn the decision. Authorization does not necessarily mean you will have no out-of-pocket expenses.
Medicare coverage may fall under Part B or Part D, depending on the plan and setting. Texas Medicaid coverage also depends on the plan and its requirements. The three Mansfield listings currently indicate that they do not accept Medicare or Medicaid; confirm this directly before scheduling. That information does not establish whether your benefits could cover treatment elsewhere.
Manufacturer savings programs exist for eligible commercially insured patients, but not for people using government insurance. Ask about current eligibility rules and which charges a program may help with; do not assume monitoring services are included.
Before starting, ask the center and insurer:
Include transportation and time away from work in your planning.
SPRAVATO® treatment takes place only in a REMS-certified healthcare setting. You self-administer the nasal spray under a healthcare provider’s direct observation; it is never sent home with you. Mansfield has three listed centers offering Spravato, but their REMS certification is not verified in these listings. Confirm certification and current appointment availability directly.
For treatment-resistant depression, the typical labeled schedule begins with twice-weekly visits during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance may be weekly or every two weeks. Your prescriber determines your schedule; do not assume those intervals will be your personal plan.
Plan for at least two hours of monitoring after each dose, plus time for check-in, preparation, and discharge assessment. You may need to stay longer. When arranging time off work, allow for the full appointment and transportation rather than reserving only a two-hour window.
You need someone else to drive you home. You must not drive or operate machinery until the next day after a restful sleep. Arrange a reliable ride for every session, identify a backup driver, and ask the center about its pickup and escort requirements before relying on a paid ride service. Consider whether you also need help with caregiving or other responsibilities that day.
If no Mansfield center is listed when you search, or local options cannot meet your needs, this directory also lists centers in Fort Worth and Dallas. Confirm certification, insurance participation, and appointment availability before committing. Compare transportation arrangements and repeated work absences—not just whether an initial appointment is available.
This directory lists three Mansfield centers offering Spravato, but their REMS certification is not verified in the listings. Ask each center to confirm that the location where you would receive treatment is currently REMS-certified. Also check whether it is accepting patients and participates in your insurance. If local options do not work, you can review listings in Fort Worth or Dallas without assuming certification or availability.
Spravato is FDA-approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A clinician must review your symptoms, treatment history, and medical risks; a diagnosis alone does not guarantee that treatment is appropriate or covered.
The three Mansfield listings currently indicate that they do not accept Medicare or Medicaid. Confirm directly, since listing information is not a benefits determination. Medicare Part B or Part D and Texas Medicaid may cover treatment depending on the plan and setting. Ask your insurer about participating locations, prior authorization, and separate medication and monitoring charges before scheduling treatment or assuming a center elsewhere accepts your coverage.
You use the nasal spray yourself under a healthcare provider’s direct observation in a REMS-certified setting. Staff monitor you for at least two hours after the dose, including watching for sedation, dissociation, breathing problems, and blood pressure increases. Discharge depends on the clinical assessment, so allow extra time. You cannot take the medication home, and someone else must drive you home after the visit.
Spravato can cause sedation, dissociation—feeling disconnected from yourself or your surroundings—respiratory depression, and increased blood pressure. Its boxed warnings also address abuse and misuse and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Discuss your health history, medications, and substance use honestly with the prescriber. Monitoring is required, and you must not drive or operate machinery until the next day after a restful sleep.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, even though one approved use addresses depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior. It does not replace hospitalization when clinically needed. If you are in crisis, call or text 988. For immediate danger or a medical emergency, call 911 rather than waiting for a treatment appointment.
Approved uses, nearby treatment centers, and medically sourced patient guides.